Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Apr;33(4):829–834. doi: 10.1128/jcm.33.4.829-834.1995

Collagenases and the serine proteinases elastase and cathepsin G in steroid-induced Pneumocystis carinii pneumonia.

A Sukura 1, Y T Konttinen 1, R Sepper 1, L Kaartinen 1, T Sorsa 1, L A Lindberg 1
PMCID: PMC228050  PMID: 7790446

Abstract

Pneumocystis carinii pneumonia (PCP) is characterized by the formation of leaky alveoli and a foamy alveolar exudate. To induce PCP, male Wistar rats were immunosuppressed by oral dexamethasone treatment for 12 weeks, during which time all rats developed PCP. Bronchoalveolar lavage fluid (BALF) was analyzed at that time and at 1, 2, and 4 weeks after the cessation of dexamethasone treatment, during which time the rats were recovering from PCP and immunosuppression (and was compared with the BALF obtained from healthy control rats), for type IV collagenase, elastase, cathepsin G, and collagenase activities. Scores for 72-kDa (matrix metalloproteinase type [MMP-2]) and 92-kDa (MMP-9) type IV collagenase-gelatinase activities correlated with those for BALF macrophages (r = 0.58; P < 0.001) and neutrophils (r = 0.66; P < 0.001), respectively, suggesting that they may, in part, be derived from these cells. However, MMP-2 was constitutively expressed and may play a role in normal tissue remodeling. MMP-9 activity was highest in the group with PCP (1.8 +/- 0.37; P > 0.05), with a gradual decline (1.0 +/- 0.48 by week 4; P > 0.05) toward normal (0.67 +/- 0.42) during recovery, which suggests a role for it in tissue-destructive inflammatory events. In rats with PCP the endogenously active collagenase was present at high levels compared with those in healthy controls (2.6 +/- 0.69 versus 0.17 +/- 0.17, respectively; P < 0.01), but they returned to normal by week 4 of recovery (0.42 +/- 0.30; P > 0.05). Collagenase activity showed a correlation with cyst number (r = 0.57; P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (610.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agostini C., Zambello R., Trentin L., Poletti V., Spiga L., Gritti F., Cipriani A., Salmaso L., Cadrobbi P., Semenzato G. Prognostic significance of the evaluation of bronchoalveolar lavage cell populations in patients with HIV-1 infection and pulmonary involvement. Chest. 1991 Dec;100(6):1601–1606. doi: 10.1378/chest.100.6.1601. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Campbell E. J., Senior R. M., Welgus H. G. Extracellular matrix injury during lung inflammation. Chest. 1987 Jul;92(1):161–167. doi: 10.1378/chest.92.1.161. [DOI] [PubMed] [Google Scholar]
  4. Collier I. E., Wilhelm S. M., Eisen A. Z., Marmer B. L., Grant G. A., Seltzer J. L., Kronberger A., He C. S., Bauer E. A., Goldberg G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988 May 15;263(14):6579–6587. [PubMed] [Google Scholar]
  5. Connor E., Bagarazzi M., McSherry G., Holland B., Boland M., Denny T., Oleske J. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV. JAMA. 1991 Apr 3;265(13):1693–1697. [PubMed] [Google Scholar]
  6. Dewald B., Bretz U., Baggiolini M. Release of gelatinase from a novel secretory compartment of human neutrophils. J Clin Invest. 1982 Sep;70(3):518–525. doi: 10.1172/JCI110643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garbisa S., Ballin M., Daga-Gordini D., Fastelli G., Naturale M., Negro A., Semenzato G., Liotta L. A. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem. 1986 Feb 15;261(5):2369–2375. [PubMed] [Google Scholar]
  8. Genner J., Settnes O. P. Pathological characteristics for the diagnosis of Pneumocystis carinii pneumonia. A retrospective autopsy study. APMIS. 1990 Dec;98(12):1098–1104. [PubMed] [Google Scholar]
  9. Gill V. J., Nelson N. A., Stock F., Evans G. Optimal use of the cytocentrifuge for recovery and diagnosis of Pneumocystis carinii in bronchoalveolar lavage and sputum specimens. J Clin Microbiol. 1988 Sep;26(9):1641–1644. doi: 10.1128/jcm.26.9.1641-1644.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirose T., Reife R. A., Smith G. N., Jr, Stevens R. M., Mainardi C. L., Hasty K. A. Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol. 1992 Apr;19(4):593–599. [PubMed] [Google Scholar]
  11. Hopewell P. C. Pneumocystis carinii pneumonia: diagnosis. J Infect Dis. 1988 Jun;157(6):1115–1119. doi: 10.1093/infdis/157.6.1115. [DOI] [PubMed] [Google Scholar]
  12. Hughes W. T. Pneumocystis carinii pneumonitis. Chest. 1984 Jun;85(6):810–813. doi: 10.1378/chest.85.6.810. [DOI] [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Mallya S. K., Van Wart H. E. Mechanism of inhibition of human neutrophil collagenase by Gold(I) chrysotherapeutic compounds. Interaction at a heavy metal binding site. J Biol Chem. 1989 Jan 25;264(3):1594–1601. [PubMed] [Google Scholar]
  15. Masur H. Clinical studies of Pneumocystis carinii and relationships to AIDS. J Protozool. 1989 Jan-Feb;36(1):70–74. doi: 10.1111/j.1550-7408.1989.tb02708.x. [DOI] [PubMed] [Google Scholar]
  16. Matsumoto Y., Yoshida Y. Sporogony in Pneumocystis carinii: synaptonemal complexes and meiotic nuclear divisions observed in precysts. J Protozool. 1984 Aug;31(3):420–428. doi: 10.1111/j.1550-7408.1984.tb02989.x. [DOI] [PubMed] [Google Scholar]
  17. McKenzie R., Travis W. D., Dolan S. A., Pittaluga S., Feuerstein I. M., Shelhamer J., Yarchoan R., Masur H. The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 1991 Sep;70(5):326–343. doi: 10.1097/00005792-199109000-00004. [DOI] [PubMed] [Google Scholar]
  18. Montgomery A. B. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention. Semin Respir Infect. 1989 Jun;4(2):102–110. [PubMed] [Google Scholar]
  19. Nakajima K., Powers J. C., Ashe B. M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem. 1979 May 25;254(10):4027–4032. [PubMed] [Google Scholar]
  20. Nielsen M. H., Settnes O. P. Morphology of Pneumocystis carinii and activation of the plasmalemmal vesicular system in alveolar epithelial cells of the host. An ultrastructural study. APMIS. 1991 Mar;99(3):219–225. [PubMed] [Google Scholar]
  21. Okada Y., Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett. 1989 Jun 5;249(2):353–356. doi: 10.1016/0014-5793(89)80657-x. [DOI] [PubMed] [Google Scholar]
  22. Phair J., Muñoz A., Detels R., Kaslow R., Rinaldo C., Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990 Jan 18;322(3):161–165. doi: 10.1056/NEJM199001183220304. [DOI] [PubMed] [Google Scholar]
  23. Salo T., Lyons J. G., Rahemtulla F., Birkedal-Hansen H., Larjava H. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem. 1991 Jun 25;266(18):11436–11441. [PubMed] [Google Scholar]
  24. Sepper R., Konttinen Y. T., Sorsa T., Koski H. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest. 1994 Oct;106(4):1129–1133. doi: 10.1378/chest.106.4.1129. [DOI] [PubMed] [Google Scholar]
  25. Shapiro S. D., Campbell E. J., Senior R. M., Welgus H. G. Proteinases secreted by human mononuclear phagocytes. J Rheumatol Suppl. 1991 Feb;27:95–98. [PubMed] [Google Scholar]
  26. Sibille Y., Reynolds H. Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990 Feb;141(2):471–501. doi: 10.1164/ajrccm/141.2.471. [DOI] [PubMed] [Google Scholar]
  27. Springman E. B., Angleton E. L., Birkedal-Hansen H., Van Wart H. E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A. 1990 Jan;87(1):364–368. doi: 10.1073/pnas.87.1.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stricklin G. P., Jeffrey J. J., Roswit W. T., Eisen A. Z. Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry. 1983 Jan 4;22(1):61–68. doi: 10.1021/bi00270a009. [DOI] [PubMed] [Google Scholar]
  29. Sukura A., Lindberg L. A., Soveri T., Guerrero O., Chinchilla M., Elvin K., Linder E. Establishment of Pneumocystis carinii infection in a rat population. Acta Vet Scand. 1991;32(1):135–137. doi: 10.1186/BF03547006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sukura A., Soveri T., Lindberg L. A. Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats. J Clin Microbiol. 1991 Oct;29(10):2331–2332. doi: 10.1128/jcm.29.10.2331-2332.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Turto H., Lindy S., Uitto V. J., Wegelius O., Uitto J. Human leukocyte collagenase: characterization of enzyme kinetics by a new method. Anal Biochem. 1977 Dec;83(2):557–569. doi: 10.1016/0003-2697(77)90059-8. [DOI] [PubMed] [Google Scholar]
  32. Uitto V. J., Turto H., Huttunen A., Lindy S., Uitto J. Activation of human leukocyte collagenase by compounds reacting with sulfhydryl groups. Biochim Biophys Acta. 1980;613(1):168–177. doi: 10.1016/0005-2744(80)90203-x. [DOI] [PubMed] [Google Scholar]
  33. Walzer P. D., Powell R. D., Jr, Yoneda K., Rutledge M. E., Milder J. E. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun. 1980 Mar;27(3):928–937. doi: 10.1128/iai.27.3.928-937.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weiss S. J., Peppin G., Ortiz X., Ragsdale C., Test S. T. Oxidative autoactivation of latent collagenase by human neutrophils. Science. 1985 Feb 15;227(4688):747–749. doi: 10.1126/science.2982211. [DOI] [PubMed] [Google Scholar]
  35. Woessner J. F., Jr Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991 May;5(8):2145–2154. [PubMed] [Google Scholar]
  36. Yoneda K., Walzer P. D. Interaction of Pneumocystis carinii with host lungs: an ultrastructural study. Infect Immun. 1980 Aug;29(2):692–703. doi: 10.1128/iai.29.2.692-703.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yoneda K., Walzer P. D. Mechanism of pulmonary alveolar injury in experimental Pneumocystis carinii pneumonia in the rat. Br J Exp Pathol. 1981 Aug;62(4):339–346. [PMC free article] [PubMed] [Google Scholar]
  38. Yoshida Y., Ikai T. Pneumocystis carinii pneumonia: epidemiology in Japan, and cyst concentration method. Zentralbl Bakteriol Orig A. 1979 Jul;244(2-3):405–410. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES